Other Content - BioPharm International

ADVERTISEMENT

Other Content

BioPharm International 2015 Editorial Calendar

October 1, 2014

BioPharm International 2015 Editorial Calendar

Waters - PEGylated Protein Analysis by Size-Exclusion and Reversed-Phase UPLC

September 30, 2014

Waters - PEGylated Protein Analysis by Size-Exclusion and Reversed-Phase UPLC

ProteinSimple - More Efficiency with Equivalent Data: MFI 5200

September 25, 2014

ProteinSimple - More Efficiency with Equivalent Data: MFI 5200

Eppendorf - Production of Stem Cells in Single-use Vessels

September 25, 2014

Eppendorf - Production of Stem Cells in Single-use Vessels

Acorda Acquires Biopharmaceutical Company Civitas Therapeutics

September 24, 2014

Acorda Therapeutics acquired Civitas Therapeutics for $525 million, giving Acorda all the rights to CVT-301, a Phase III candidate for off episodes of Parkinson?s disease.

Rigaku - Minimizing Excipient Fluorescence Interference Using Handheld Raman

September 23, 2014

Rigaku - Minimizing Excipient Fluorescence Interference Using Handheld Raman

GE Healthcare - Efficient, high-titer monoclonal antibody production in a fed-batch process using single-use stirred-tank and rocking bioreactor systems

September 22, 2014

GE Healthcare - Efficient, high-titer monoclonal antibody production in a fed-batch process using single-use stirred-tank and rocking bioreactor systems

BioRad - Mammalian Virus Purification Using Ceramic Hydroxyapatite

September 22, 2014

BioRad - Mammalian Virus Purification Using Ceramic Hydroxyapatite

EMD Serono Collaborates with Sutro Biopharma to Develop ADCs

September 18, 2014

EMD Serono announces a collaboration with Sutro Biopharma to develop antibody drug conjugates for multiple undisclosed targets.

ADVERTISEMENT

ADVERTISEMENT

Click here